Discovery of 4-(1,2,4-Oxadiazol-5-yl)azepan-2-one Derivatives as a New Class of Cannabinoid Type 2 Receptor Agonists for the Treatment of Inflammatory Pain-Reference-Cited by-同舟云学术

Discovery of 4-(1,2,4-Oxadiazol-5-yl)azepan-2-one Derivatives as a New Class of Cannabinoid Type 2 Receptor Agonists for the Treatment of Inflammatory Pain

Published:2023-02-23 Issue:5 Volume:66 Page:3460-3483
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Nan Jinshan¹,Liu Jingming¹,Lin Guifeng¹,Zhang Shanshan¹,Xia Anjie¹^ORCID,Zhou Pei²,Zhou Yangli¹,Zhang Jiahao¹,Zhao Jinlong¹,Zhang Shiyu²,Huang Chong¹,Wang Yifei¹,Hu Qian¹,Chen Junxian³,Xiang Mingli¹,Yang Xin¹,Yang Shengyong¹^ORCID

Affiliation:

1. State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China

2. Key Laboratory of Drug Targeting and Drug Delivery System of Ministry of Education, West China School of Pharmacy, Sichuan University, Chengdu, Sichuan 610041, China

3. Key Laboratory of General Chemistry of the National Ethnic Affairs Commission, School of Chemistry and Environment, Southwest Minzu University, Chengdu Sichuan 610041, China

Funder

China Postdoctoral Science Foundation

Department of Science and Technology of Sichuan Province

National Natural Science Foundation of China

1.3.5 project for disciplines of excellence, West China Hospital, Sichuan University

Post-Doctor Research Project, West China Hospital, Sichuan University

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.2c01943